# Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism

> **NCT06135948** · PHASE4 · COMPLETED · sponsor: **Emirates Health Services (EHS)** · enrollment: 103 (actual)

## Conditions studied

- L-thyroxine

## Interventions

- **DRUG:** Extra dose of L-thyroxine, 25 mcg during Ramadan

## Key facts

- **NCT ID:** NCT06135948
- **Lead sponsor:** Emirates Health Services (EHS)
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-15
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06135948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06135948, "Impact of Increasing Levothyroxine Dose in Ramadan for UAE Patients With Hypothyroidism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06135948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*